Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Purpose of Investigation: A retrospective cohort study was performed to identify whether myomectomy at the time of cesarean delivery leads to an increased risk of intrapartum and short-term postpartum complications. The authors’ aim is to investigate the short-term outcomes of women who have undergone a cesarean myomectomy. Materials and Methods: This study included the cases that had undergone cesarean myomectomy between January, 2008 and December, 2015. Two hundred twenty-seven pregnant women with uterine myomas who delivered via cesarean section were identified. One hundred two women underwent cesarean myomectomy. The authors compared the maternal characteristics, type of myomas, neonatal weight, and operative outcomes between the two groups. Results: Two group analysis revealed that there were no significant differences in the mean hemoglobin change (1.5 ± 1.0 vs. 1.2 ± 0.9 mg/dL), and the length of hospital stay (3.9 ± 1.2 vs. 3.3 ± 1.4 days) between two groups. The operative time of myomectomy group was significantly longer (88.5 ± 19.5 vs. 58.0 ± 20.4 min, p < 0.01). No patient in either group required hysterectomy or embolization. Conclusions: Myomectomy during cesarean delivery does not appear to result in an increased risk of intrapartum or short-term postpartum morbidity.